Back to catalogue
Tesamorelin 10mg vial
10mg
Research compound

Tesamorelin

Targets belly fat and boosts growth hormone

$110
AUD · 10mg
BAC water included free
Reference grade · For laboratory research only
Quick overview

In plain English

Targets belly fat and boosts growth hormone.

The science

Mechanism & research

Tesamorelin is a stabilised 44-amino-acid GHRH analogue, FDA-approved for HIV-associated lipodystrophy. It binds pituitary GHRH receptors to drive physiological pulsatile GH secretion, restoring IGF-1 levels without disrupting feedback regulation. Trials show a ~15–20% reduction in visceral adipose tissue measured by CT after 26 weeks, along with improvements in triglycerides, adiponectin, and cognitive markers, while preserving subcutaneous fat and insulin sensitivity.

Research use disclaimer: This product is supplied strictly for in-vitro laboratory research and analytical reference. It is not a pharmaceutical, is not approved by the TGA for human therapeutic use, and must not be administered to humans or animals.

More compounds